⚠️ Research Notice: This information is for educational and laboratory research purposes only. Not for human consumption.
GLP-1 Family
high Confidence
Semaglutide
Last Updated: January 2025
Key Takeaways: Semaglutide
Semaglutide is a GLP-1 peptide primarily researched for:
- Improved glycemic control
- Significant weight loss
- Cardiovascular risk reduction
Research Profile
Stability Class Robust
Confidence high
Freezable? ❌ No (Fragile)
Semaglutide is a GLP-1 receptor agonist that mimics the action of the glucagon-like peptide-1 hormone. It increases insulin secretion, slows gastric emptying, and reduces appetite.
Research Context
Originally developed for Type 2 Diabetes (Ozempic), it is now FDA approved for chronic weight management (Wegovy).
Handling Usage
Due to its long half-life (~7 days), it is typically administered once weekly.
Clinical Data & Studies
Key Benefits
- Improved glycemic control
- Significant weight loss
- Cardiovascular risk reduction
Potential Side Effects
- Nausea
- Vomiting
- Diarrhea
- Fatigue
Stability Profile
Fridge (2-8°C)
Very Stable (> 8 weeks)
Room Temp
Stable for weeks, but keep cool